Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

Immune checkpoint inhibitors (ICIs) have made significant breakthroughs in the treatment of a variety of malignancies. As its use increases, the unique immune-mediated toxicity profile of ICls are becoming apparent. We report a case of immune-related endocrine adverse events (irAE) in a patient with...

Full description

Bibliographic Details
Main Authors: Liman Huo, Chao Wang, Haixia Ding, Xuelian Shi, Bin Shan, Ruoying Zhou, Ping Liang, Juan Hou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Oncology
Subjects:
tislelizumab
immune-related adverse events
hyperthyroidism
hypothyroidism
thyroiditis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1190491/full

Similar Items

Similar Items